Publications
87
Citations
6,464
Est. group size
—
Recurring co-author estimate
Active years
28
Publishing since 1999
Junshui Ma's work centers on applying computational and data-analysis methods to cancer research, particularly identifying biomarkers (such as PD-L1 and tumor mutational burden) that help predict which patients respond to immunotherapy drugs like pembrolizumab. More recent work extends into using artificial intelligence, including large language models and reinforcement learning, to support clinical research tasks such as data extraction from oncology trials and treatment decision-making. This research is relevant to students interested in the intersection of oncology, biomarker discovery, and applied machine learning in healthcare.
Publication output has been variable but shows an overall increase in recent years, rising from low single digits in 2017-2019 to a peak of 10 in 2024, with continued output projected into 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Process control of elemental mixing in laser powder bed fusion of dissimilar Al/Zn alloys
Journal of Manufacturing Processes · 2026
- WCN26-8650 REINFORCEMENT LEARNING FOR DYNAMIC TREATMENT OF CHRONIC KIDNEY DISEASE MINERAL AND BONE DISORDER (CKD-MBD) AMONG PATIENTS WITH KIDNEY FAILURE ON HEMODIALYSIS: A DEMONSTRATION PROJECT
Kidney International Reports · 2026
- RAG-X-Driven Construction of an Intelligent Platform for Teaching Assistance in Higher Education
2025
- Automated clinical data extraction from oncology trials using large language models.
Journal of Clinical Oncology · 2025
- ClinicalRAG: Automating Pharmaceutical Label Quality Control with Hierarchical RAG and Large Language Models
Proceedings of the AAAI Conference on Artificial Intelligence · 2025
- Creating a Proxy for Baseline Eastern Cooperative Oncology Group Performance Status in Electronic Health Records for Comparative Effectiveness Research in Advanced Non–Small Cell Lung Cancer
JCO Clinical Cancer Informatics · 2025
- Supplementary Figure S4 from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
2024
- Data from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
2024
- Supplementary Figure S1 from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
2024
- Supplementary Table S1 from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
2024
- Supplementary Figure S3 from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
2024
- Supplementary Figure S2 from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
2024
- Supplementary Table S2 from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
2024
- Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffs
Bioanalysis · 2024
- Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
Clinical Cancer Research · 2024
- Journal of Clinical Oncology×7
- Journal of Chemical Information and Modeling×3
- arXiv (Cornell University)×3
- Cancer Research×2
- Pathology×2
- Lynne Brophy
Medicine · The Ohio State University
- Lingbin Meng
Medicine · The Ohio State University
- Yuanquan Yang
Medicine · The Ohio State University
- Na Zhuo
Medicine · Purdue University West Lafayette
- Adam Khorasanchi
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile